In CML, it has been widely reported that the BCR-ABL aberrant kinase activity induces MYC transcription [48] and translation, and that the progress into blast crisis depends on this BCR-ABL-induced MYC expression [49]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.